Active Ingredients: AdalimumabStrength: 40 mg/0.8 mlDosage Form: Syringe, VialMechanism of Action: TNF-alpha inhibitorsFirst Approval: US (Dec 31, 2002), EU (Aug 09, 2003)RevenueHumira (adalimumab) has been the top-selling biologic drug product for the last few years – reaching nearly $21B in annual sales in 2021. Humira is one of the main drivers of AbbVie’s immunology…

The year 2021 witnessed the global approval of vaccines and drugs amid COVID-19. The disease has been dominating the headlines from the last two years.No one is amazed that COVID vaccines and drugs find a place in top selling drugs this time. Pfizer & BioNTech’s Comirnaty took the first position with $36B revenue and…